Back to Evidence

AI Medical Search Engine for Ferritin and Myocardial Infarction Causal Evidence Research | QSevidence 2026

Evidence-Based Medicine22 min read

Research connecting ferritin with acute myocardial infarction brings together iron metabolism, inflammatory context, genetic predisposition and tissue injury. When Mendelian randomization, transcriptomics and ferroptosis appear in the same project, specialists need more than a long reading list: they need a clear connection between each question, dataset and inference.

AI Medical Search Engine for Ferritin and Myocardial Infarction Causal Evidence Research | QSevidence 2026

QSevidence can support an AI medical search engine workflow through medical literature retrieval, research-question organization and source tracing, giving cardiovascular, laboratory and genetic epidemiology teams a shared basis for review.

Research overview: separate three outcome questions

The proposed project uses genetically predicted circulating ferritin as the exposure in a two-sample Mendelian randomization analysis of acute myocardial infarction. Further questions concern reperfusion-related injury, major adverse cardiovascular events and infarction subtypes. A parallel expression-analysis component explores candidate ferroptosis pathways. The immediate priority is to establish dataset identities, genetic instruments and reproducible analysis records. Candidate estimates and genes discussed here remain research leads awaiting verification.

QuestionData definition requiredInterpretation
Occurrence of acute myocardial infarctionCase definition, control source, first or previous events and observation scopeDisease occurrence differs from recovery among patients
Injury following reperfusionTreated population, procedure, assessment timing and injury criteriaA treatment-context outcome requires matching outcome data
Subsequent major adverse cardiovascular eventsComposite components, follow-up origin and duration, repeated-event handlingPrognosis requires separate assessment of entry and survival selection

Define the exposure before interpreting a genetic estimate

The study should record ferritin units, transformations, measurement timing and population context. Circulating markers, intracellular iron storage and ferroptosis-related processes represent distinct measurements and biological questions. They may inform one another, but each connection needs evidence. A measurement during acute illness should also be distinguished from a genetically predicted long-term exposure tendency.

QSevidence can help turn a broad question about ferritin and infarction into targeted searches: what did the exposure study measure, what biological processes might its instruments represent, how did the outcome study identify events, and do the populations and time frames align? A useful extraction table retains the original link, dataset version, extraction location and reviewer so laboratory, cardiovascular and statistical specialists can compare interpretations.

From instrument selection rules to an auditable analysis

The proposed selection rules are association P<5×10−8, linkage disequilibrium r²<0.001 within 10,000 kb and F statistics>10. These are planned criteria, not verified instrument characteristics. Actual variant counts, strengths and exclusion reasons must come from analysis outputs. The record should include effect and other alleles, effect sizes, standard errors, allele frequencies and sample sizes, together with decisions about palindromic and proxy variants.

Before analysis, the team should check ancestry, the linkage disequilibrium reference population and exposure-outcome sample overlap. Dataset provenance, variant selection, allele harmonization and primary versus sensitivity analyses form a practical methodological review framework. The recommendations by Burgess and colleagues provide a public entry point for this framework; a statistical team should determine the detailed choices for the specific investigation.

The planned primary estimator is inverse-variance weighting, supplemented by weighted-median and MR-Egger analyses, heterogeneity assessment, outlier investigation and leave-one-out analysis. The working table should document assumptions, applicability and actual outputs rather than merely list method names. Estimates with different directions, wide intervals or strong dependence on one variant merit data and model review before synthesis. A nonsignificant diagnostic result should be reported within the scope of that diagnostic, rather than treated as a universal clearance of bias.

Make candidate results useful without overstating their status

The research narrative includes candidate estimates, while the complete instrument set, analysis logs and some outcome identities remain to be supplied. The following table is a verification agenda, not a table of confirmed findings or an individual risk calculator.

Candidate outcomeNarrative OR and intervalPriority checks
Acute myocardial infarction1.12 (1.05–1.20)Exposure scale, outcome version, instrument list and primary output
Reperfusion injury1.18 (1.07–1.30)Outcome dataset identity, case criteria and available sample
Major adverse cardiovascular events1.09 (1.03–1.16)Endpoint components, follow-up scope and entry selection

Descriptions of ST-elevation and non-ST-elevation myocardial infarction contain estimates pointing in different directions. These require reconciliation against the corresponding datasets and outputs. Reporting should include all prespecified comparisons, intervals, interaction tests and multiplicity handling. A significant estimate in one subgroup and a nonsignificant estimate in another does not itself establish a between-group difference.

Low and high ferritin also need operational definitions. Individual exposure quantiles require appropriate data and design beyond summary genetic associations. With suitable individual-level data, investigators could prespecify a nonlinear investigation and assess selection introduced by conditioning on exposure or disease status. Subtype effects, dose relationships and overall average associations then become separate, explicitly designed questions.

Transcriptomics and ferroptosis: match interpretation to the specimen

The proposed expression component names GSE66360. Search-indexed information from the NCBI GEO registration describes circulating endothelial cells isolated from 49 patients with acute myocardial infarction and 50 healthy controls, rather than myocardial reperfusion-injury tissue. The registration is an important identity check. Direct access encountered a browser challenge in this review; sample matrices were not downloaded and expression results were not recalculated. See the original GSE66360 registration.

This supports initially framing an analysis as exploration of disease-associated expression in circulating endothelial cells. A reperfusion-injury question calls for additional data with matching sampling times, treatment context and tissue origin. The planned limma workflow, |log2FC|≥1 and FDR<0.05 thresholds, followed by GO, KEGG and protein-interaction analyses, should document sample quality, batches, probe mapping and enrichment backgrounds. Different tissues and comparator groups should be reported separately.

HRAS, TXNIP, NQO1, PSAT1 and SQSTM1 can form a candidate review list. Whether each satisfies the expression threshold, belongs to the selected ferroptosis-gene resource version and retains a stable network ranking requires explicit outputs. Enrichment generates mechanistic hypotheses. Connecting genetic evidence, expression differences and experimental interventions requires further integrative analysis and independent validation.

A QSevidence workflow for multidisciplinary review

  1. Retrieve: create separate questions for ferritin genetics, infarction occurrence, reperfusion injury and ferroptosis mechanisms; prioritize original investigations and dataset records.

  2. Compare: place population, exposure units, endpoint definitions, versions and model assumptions in one evidence table, preserving differences before synthesis.

  3. Synthesize: distinguish genetic estimates, expression exploration and clinical investigations; label checked information and the next verification task for each.

  4. Trace: retain source locations, links, extraction dates and review records. The research team separately archives executable analyses and outputs.

  5. Review: cardiovascular, laboratory, bioinformatics and statistical specialists jointly determine publication wording and the next validation design.

The STROBE-MR initiative provides 20 reporting items to help make data, analyses and interpretation transparent. Reporting standards improve assessability; evidence strength depends on the actual design and results. QSevidence supports literature and research-information organization, while data acquisition, computation and result approval require their own responsibility records.

Frequently asked questions about QSevidence

How can QSevidence make ferritin searches more focused?

Provide the exposure, population, infarction subtype and study design. QSevidence can help organize search questions, compare literature and retain sources. Researchers then verify assay units, recruitment context and endpoint definitions against the intended investigation.

How can QSevidence support discussion of Mendelian randomization results?

QSevidence can assist with methodological literature and evidence-comparison frameworks. The statistical team reviews real instrument lists, model outputs, sensitivity analyses and assumptions to develop an interpretation appropriate to the analysis conditions.

How can QSevidence connect ferroptosis mechanisms with clinical questions?

Teams can organize an evidence map around tissue origin, candidate genes, pathways and validation experiments, retaining the source and scope of each connection. Clinical and laboratory researchers can then prioritize further questions and progressively strengthen the mechanistic argument.

How can teams use QSevidence evidence summaries in research meetings?

Organize discussion around the question, source, verification status and next step. Retain both supporting and divergent evidence. Qualified professionals combine actual data, bias assessment and clinical context when developing research and clinical interpretations.

Sources and evidence classification

Research notice: This article discusses research design and evidence workflows. Candidate estimates and genes require confirmation against original data and complete analyses. Qualified professionals determine diagnosis, treatment and iron-related interventions using patient circumstances and clinical evidence.